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Uncompetitive inhibition is much less common in nature than consideration of enzyme structure and mech- 
anism might lead one to expect. A possible explanation may be that uncompetitive inhibition of an enzyme 
in a metabolic pathway can have enormously larger effects on the concentrations of metabolic Intermediates 
than competitive inhibition, under circumstances where their effects on the kinetics of the isolated enzyme 
are very similar. The severely toxic effects that an uncompetitive inhibitor might be expected to have may 
have caused enzymes to have evolved in such a way that there has been selection against structures that 
might favour uncompetitive inhibition. 
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1. INTRODUCTION 
No one who has taught or written about enzyme 
kinetics and made a conscientious effort to provide 
examples of the kinds of behaviour regarded as im- 
portant can fail to have been struck by the extreme 
paucity of examples of uncompetitive inhibition. It 
occurs, not particularly often, as a special case of 
product inhibition when the inhibiting product is 
isolated from the substrate by irreversible steps [ 11, 
but cases of uncompetitive inhibition by species 
that are not involved in the reaction are virtually 
unknown: the only example that I can find is the 
uncompetitive inhibition of alkaline phosphatase 
by L-phenylalanine [2]. Moreover, although mixed 
inhibition, in which both competitive and un- 
competitive components are present, is quite com- 
mon, the competitive component is nearly always 
dominant. 
A conventional explanation might be that it is 
not particularly plausible in general to suppose 
that an inhibitor can only exert an effect on the 
enzyme-substrate complex and not on the free en- 
zyme. While this may be valid as an explanation of 
why competitive inhibition is much more common 
than uncompetitive, it hardly explains the almost 
total absence of the latter. Moreover, it is not ob- 
vious why in cases where the inhibitor binds to 
both free enzyme and enzyme-substrate complex it 
normally binds much more tightly to the free en- 
zyme. Although steric interference may account 
for some examples, one would expect there to be 
others in which ionic or conformational effects 
would cause the inhibitor to potentiate binding of 
substrate. Moreover, simple kinetic analysis in- 
dicates that an unreactive analogue of a substrate 
in a substituted-enzyme (‘ping pong’) mechanism 
should act as an uncompetitive inhibitor with 
respect o the other substrate, and that an unreac- 
tive analogue of the first product to be released in 
a compulsory-order ternary-complex mechanism 
should act in this way with respect to the first 
substrate. However, actual experimental examples 
of these kinds are hard to find; for illustrating un- 
competitive inhibition one is usually forced to rely 
on extrapolating observable behaviour to 
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saturating (i.e. infinite) concentrations of one 
substrate, which does not, of course, represent a 
genuine example. 
This raises the possibility that uncompetitive f- 
fects may not merely be mechanistically implausi- 
ble but may be so detrimental to organisms that 
display them that there has been evolutionary 
selection against such inhibition by naturally oc- 
curring metabolites. It may therefore be wor- 
thwhile to point out that any metabolic pathway in 
which uncompetitive inhibition can occur can 
potentially respond catastrophically to the 
presence of the inhibitor, as I shall now discuss. 
2. THEORY AND RESULTS 
When considering isolated enzymes in vitro, it is 
almost universal practice to regard the rate of reac- 
tion as a dependent variable determined by the 
concentrations chosen by the experimenter. Atkin- 
son [3] has cogently discussed why this is quite 
unrealistic for considering enzymes in vivo. As an 
alternative, he suggests that for many enzymes it is 
appropriate to regard the rate as the independent 
variable, with metabolite concentrations deter- 
mined by it. The most realistic but more com- 
plicated approach is to compromise between this 
view and the conventiona one, as I try to do 
below, but Atkinson’s viewpoint provides a conve- 
nient and simple starting point for considering why 
competitive and uncompetitive inhibition should 
have entirely different consequences in vivo. 
If a metabolite X is produced at a constant rate 
v and consumed according to Michaelis-Menten 
kinetics with maximum veiocity I/ and Michaelis 
constant K,,,, it is a simple matter to show that the 
steady-state concentration of X will be given by the 
following expression: 
&J 
x - 
SS - (V/v)- 1 
When an inhibitor is present, I/ and ic;, must be 
replaced by ‘apparent’ values, YaPp and PZp, 
respectively. For competitive inhibition, &?,Zp is a 
linear function of the inhibitor concentration, but 
Ppp is independent of the inhibitor; thus in this 
case xSS is a linear function of the inhibitor concen- 
tration. If the inhibition is uncompetitive, 
4 
however, with inhibition constant Ki”, then 
K”,p* = K,,,/(l + i/K,,) 
Yap’ = V/(1 + i/Ki,) 
and x,,is given by an expression that has no finite 
positive value unless i/K,, is less than (V/v - 1): 
x - KIII 
Ss - (V/v) - 1 - (i/K,“) 
Various authors (4-61 have commented that in 
vivo substrate concentrations are likely to be 
somewhat below the appropriate &, values, and it 
has sometimes been suggested that one should ex- 
pect them to be higher [7]. In any event they are 
likely to be of the same order of magnitude, and it 
is not unreasonable as a first approximation to put 
v = OSV, or c/‘/v = 2, which would imply that no 
steady state exists if i exceeds the inhibition con- 
stant iui,* 
As this result is at first sight very surprising, it 
may be helpful to try to rationalize it in conceptual 
terms. Whenever a step in a metabolic process is 
inhibited, one of the first effects will be an increase 
in concentration of the substrate or substrates of 
the inhibited step. This will happen regardless of 
the type of inhibition, but the secondary effects 
will be highly dependent on the type of inhibition: 
if it is competitive, an increasing substrate concen- 
tration will tend to overcome it, and so the system 
is able to adjust with little difficulty; if it is un- 
competitive, however, the presence of a term in is 
in the rate equation means that the substrate tends 
to potentiate the inhibition, and the more the 
substrate concentration rises the more the reaction 
approaches the limiting-rate condition in which 
uncompetitive inhibition is most effective. 
As mentioned above, however, this constant- 
rate case is as much of an extreme as the more 
usual constant-concentration case. In a real 
metabolic system it is no more valid to take the 
concentrations as determined by the rates than to 
take the rates as determined by the concentrations; 
instead, it is now becoming recognized that control 
is shared between all elements of the system [8,9]. 
This complicates the analysis but it does not in- 
validate it, as may be seen from the curves plotted 
in fig.1. These show the concentration of the 
substrate of the fifth enzyme in a linear pathway as 
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Fig.1. Different effects of competitive and un- 
competitive inhibitors on the concentration of an 
intermediate in a metabolic pathway. The pathway 
consists of a linear sequence of enzyme-catalysed 
reactions from A to K, each with an equilibrium 
constant of 10 in favour of product, and proceeding at 
a rate equal to (10s - p)/( 1 + s + p), where s and p are 
the concentrations of the substrate and product of the 
reaction in question. In the case of the fifth reaction, the 
rate is (10s - p)/(l + s + p + r) for competitive 
inhibition by an external species at concentration i, or 
(10s - p)/(l + s + p + sr) for uncompetitive inhibition. 
The concentrations of A and K were set at 1.035 and 0, 
respectively, values that give a value of 1.000 for the 
concentration of the substrate of the fifth enzyme in the 
absence of inhibitors. At these concentrations and in the 
absence of inhibition the flux control coefficients for the 
ten enzymes are, in the order in which they appear in the 
pathway, 0.424,0.245,0.141,0.081,0.046,0.026,0.014, 
0.008,0.004 and 0.001. The computer program used for 
simulating the pathway is described and reproduced in 
full elsewhere [131. 
a function of the concentrations of external com- 
petitive and uncompetitive inhibitors with inhibi- 
tion constants equal to the substrate concentration 
that exists in the absence of inhibition. Both curves 
have the same tangent at the axis, i.e. the same in- 
itial slope, but whereas the curve for the com- 
petitive inhibitor is almost straight, the one for the 
uncompetitive inhibitor is highly curved and rises 
very steeply at inhibitor concentrations not much 
larger than K,,. For both types of inhibition the 
substrate concentration eventually levels out at the 
equilibrium value of 10000. 
3. DISCUSSION 
The degree to which the behaviour of an in- 
termediate in a metabolic pathway resembles the 
theoretical case for a constant rate depends in part 
on how far its normal physiological concentration 
is removed from equilibrium with the reservoir of 
precursor. In the example illustrated in fig.1, the 
equilibrium value of the substrate concentration 
for the inhibited enzyme was lOOOO-times greater 
than its normal value. In a real pathway the cor- 
responding values will vary widely, but in general 
we can expect that intermediates separated by 
several steps from the precursor pool the factor 
will be large. For example, in the presence of hex- 
okinase, hexose-phosphate isomerase and phos- 
phofructokinase but not aldolase the concentra- 
tion of fructose 1,6-bisphosphate could in prin- 
ciple rise to about 3 x 106-times the glucose con- 
centration, assuming an [ATP]/[ADP] ratio of 
about 5, if other effects did not intervene. 
In addition one must consider the flux control 
coefficient C~i [ 10,111 of the inhibited enzyme, i.e. 
the partial derivative of the logarithm of the 
pathway flux v with respect o the logarithm of the 
concentration Ei of the inhibited enzyme: 
Cgi = ?l!K 
&iEi 
In the pathway illustrated in fig.1, enzyme 5 has a 
flux control coefficient of 0.046, but enzymes later 
in the pathway have lower values and resemble the 
simple case more closely, whereas enzymes near 
the beginning of the pathway have higher values 
and show comparatively small effects for either 
kind of inhibition. In every case, however, an un- 
competitive inhibitor has a much larger effect than 
a competitive inhibitor on the concentration of the 
substrate of the inhibited enzyme. 
The pathway illustrated is somewhat artificial 
(all enzymes obeying the same kinetics with the 
same equilibrium constant, etc.), but its 
characteristics were chosen to facilitate concise 
definition rather than to produce a particular 
result; qualitatively similar behaviour can easily be 
generated with more realistic pathways. It may be 
questioned, however, whether it is realistic that the 
flux-control coefficients for the later enzymes in 
the pathway are all very small. A general answer to 
5 
Volume 203, number 1 FEBS LETTERS July 1986 
this will have to await a much larger body of ex- 
perimental data than exists at present. However, it 
is of interest hat a recent study of the metabolism 
of the aromatic amino acids [12] showed under a 
variety of conditions that control resided almost 
wholly in the first two steps of the pathway (in- 
cluding transport across the plasma membrane as 
the first step). 
The implication that uncompetitive inhibition by 
naturally occurring metabolites is so detrimental to 
living organisms that it has been actively selected 
against is not, unfortunately, easy to test ex- 
perimentally. Nonetheless, the theory outlined 
here has important practical implications for the 
design of toxic substances, e.g. for pest control. 
Naively, one might suppose that it would be best to 
try to find a compound that acted as a competitive 
inhibitor on a ‘key’ enzyme in a major metabolic 
pathway (more properly, an enzyme with a large 
flux control coefficient for the flux through its 
own reaction). Unfortunately, however, this 
strategy is likely to give a compound of negligible 
toxicity, because competitive inhibition within a 
pathway has little effect on either rates or concen- 
trations, and because inhibition of the enzyme with 
the highest flux control coefficient has com- 
paratively little effect on metabolite concentra- 
tions. Instead one should try to find an un- 
competitive inhibitor of an enzyme with a very 
small flux control coefficient. Although this will 
certainly be much more difficult, it is likely to be 
far more rewarding, because any such inhibitor is 
much more likely to have a major toxicological or 
pharmacological effect. 
The analysis is not greatly complicated by con- 
sidering mixed inhibition instead of uncompetitive, 
because the competitive component in the inhibi- 
tion has little practical consequence for this pur- 
pose. The essential point is that severe toxic effects 
of an inhibitor are likely to occur if the un- 
competitive inhibition constant is low enough to be 
exceeded by the inhibitor concentration. 
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